GO:0086047 membrane depolarization during Purkinje myocyte cell action potential: Cardiac Conduction Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0086047 describes the phase of the Purkinje myocyte action potential in which membrane potential moves in the depolarizing direction from the negative resting potential toward the positive peak.
• Purkinje myocytes are specialized cardiac conduction cells whose rapid depolarization ensures synchronous ventricular activation.
• Depolarization depends on voltage-gated sodium and calcium currents, and is modulated by potassium currents and electrotonic coupling to surrounding myocardium.
• Disruption of Purkinje myocyte depolarization can generate early afterdepolarizations and triggered arrhythmias.
• Experimental study of this process uses single-cell voltage clamp, microelectrode validation, and isolated Purkinje myocyte preparations.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models allow causal testing of ion-channel and regulatory genes in this pathway.
Description
GO:0086047, membrane depolarization during Purkinje myocyte cell action potential, is a biological process term that captures the rapid shift of a Purkinje myocyte membrane potential from its negative resting value toward the positive peak of the action potential. Purkinje myocytes form the specialized ventricular conduction network, and their depolarization is a critical determinant of coordinated ventricular activation. Because the Purkinje system conducts impulses far faster than ordinary working myocardium, the ionic mechanisms underlying this depolarization have direct consequences for cardiac rhythm. At the cellular level, depolarization of Purkinje myocytes is produced by the opening of voltage-gated ion channels and is shaped by the balance of inward and outward currents. Single-cell voltage clamp studies have been essential for resolving these currents and for distinguishing Purkinje myocyte behavior from that of ventricular myocytes. The process is also sensitive to electrotonic interactions with neighboring cells, which can suppress or unmask abnormal depolarizing events. For researchers, GO:0086047 provides a precise annotation target when studying conduction-system electrophysiology, arrhythmia mechanisms, and the effects of pharmacological or genetic perturbation. It is distinct from depolarization in working myocardium and from other phases of the Purkinje action potential, making it valuable for ontology-driven analysis of cardiac excitability.
membrane depolarization during Purkinje myocyte cell action potential At A Glance
| GO ID | GO:0086047 |
|---|---|
| GO term | membrane depolarization during Purkinje myocyte cell action potential |
| Ontology | biological_process |
| Synonym | None listed in QuickGO |
| Major function | Rapid depolarization of Purkinje myocyte membrane potential toward the action potential peak |
| Cell type | Purkinje myocyte of the cardiac ventricular conduction system |
| Direction of potential change | Depolarizing (from negative resting potential toward positive peak) |
| Related process | Cardiac action potential and impulse conduction |
| Disease relevance | Arrhythmia and conduction disturbance mechanisms |
What Is GO:0086047?
In plain terms, GO:0086047 is the part of a Purkinje myocyte action potential in which the cell membrane potential becomes less negative, moving from the resting potential toward the positive peak. This depolarizing phase is driven by inward ion currents and is a prerequisite for the subsequent repolarization and refractory phases of the conduction-cell action potential.
Why Is membrane depolarization during Purkinje myocyte cell action potential Important in Cell Biology?
GO:0086047 is important because the Purkinje myocyte depolarization phase determines how quickly and reliably the ventricular conduction system can activate the heart, and abnormalities in this process are linked to arrhythmogenesis. Understanding the ionic currents and electrotonic interactions that control this depolarization helps researchers interpret drug effects, genetic variants, and disease phenotypes in cardiac electrophysiology.
• Defines a specific phase of the Purkinje myocyte action potential, enabling precise ontology annotation.
• Underpins rapid impulse conduction through the ventricular conduction system.
• Provides a framework for interpreting voltage-clamp measurements of cardiac ion currents.
• Helps explain how calcium-channel blockers and other drugs alter cardiac excitability.
• Supports investigation of early afterdepolarizations and triggered activity in Purkinje cells.
• Allows comparison of Purkinje myocyte electrophysiology with working myocardial cells.
• Guides antiarrhythmic drug development and safety pharmacology.
• Enables causal testing of ion-channel genes using CRISPR models.
• Connects cellular electrophysiology to clinical arrhythmia mechanisms.
• Supports bioinformatic enrichment of cardiac conduction gene sets.
What Happens During membrane depolarization during Purkinje myocyte cell action potential?
Resting state and threshold
In simple terms: The Purkinje cell starts electrically negative and must reach a threshold before it fires.
Purkinje myocytes maintain a negative resting membrane potential, and depolarization begins when an incoming impulse brings the membrane to threshold. The transition from rest to threshold is influenced by the passive and active properties of the Purkinje cell membrane and by electrotonic current from adjacent tissue.
Inward current activation
In simple terms: Ion channels open and let positive charge flow into the cell.
Once threshold is reached, voltage-gated inward currents activate and drive the membrane potential in the depolarizing direction toward the action potential peak. Single-cell voltage clamp studies have been central to resolving the time- and voltage-dependent behavior of these currents in cardiac cells.
Current balance and action potential peak
In simple terms: The cell reaches its positive peak when inward and outward currents balance.
The depolarizing phase is shaped by the interplay between inward currents and opposing outward potassium currents, which together determine the rate of rise and the peak potential. Calcium-channel blockers can modify this balance and thereby alter depolarization and conduction.
Electrotonic interactions with coupled cells
In simple terms: Neighboring cells can electrically pull on the Purkinje cell and change how it depolarizes.
Coupling to a depolarized model cell can induce spontaneous activity in rabbit Purkinje myocytes, showing that electrotonic interactions modulate depolarization behavior. Conversely, electrotonic suppression can abolish early afterdepolarizations in isolated rabbit Purkinje myocytes.
Pharmacological and pathological modulation
In simple terms: Drugs and disease states can change how the Purkinje cell depolarizes.
Antiarrhythmic agents such as N-acetyl procainamide can exert both antiarrhythmic and arrhythmogenic effects on cardiac tissue. The pathophysiologic mechanisms of cardiac arrhythmias frequently involve altered depolarization and repolarization in specialized conduction cells.
Key Genes Involved in GO:0086047 membrane depolarization during Purkinje myocyte cell action potential
The genes and proteins most relevant to GO:0086047 are those encoding cardiac ion channels, calcium-handling proteins, and conduction-system markers that shape Purkinje myocyte depolarization.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SCN5A | Voltage-gated sodium channel alpha subunit carrying fast inward current | Core determinant of depolarization rate in cardiac cells |
| SCN1B | Sodium channel auxiliary subunit | Modulates sodium current availability during depolarization |
| CACNA1C | L-type calcium channel alpha subunit | Contributes to inward current and is a calcium-channel blocker target |
| CACNA1D | Calcium channel alpha subunit | Supports inward calcium current in conduction cells |
| CACNB2 | Calcium channel beta subunit | Regulates calcium channel trafficking and gating |
| KCNQ1 | Potassium channel alpha subunit | Opposing outward current shaping depolarization peak |
| KCNH2 | Potassium channel alpha subunit | Repolarizing current that balances inward currents |
| KCNJ2 | Inward rectifier potassium channel | Sets resting potential and modulates excitability |
| HCN4 | Hyperpolarization-activated cyclic nucleotide-gated channel | Contributes to pacemaker-like currents in conduction tissue |
| GJA1 | Connexin 43 gap junction protein | Mediates electrotonic coupling between cardiac cells |
| GJA5 | Connexin 40 gap junction protein | Supports fast conduction in Purkinje system |
| ATP2A2 | SERCA2 calcium pump | Regulates intracellular calcium during excitation-contraction coupling |
| RYR2 | Ryanodine receptor calcium release channel | Links calcium handling to membrane potential changes |
| NPPA | Natriuretic peptide precursor A | Marker of myocardial stretch and conduction tissue phenotype |
| MYH7 | Beta-myosin heavy chain | Contractile marker used to identify myocardial cell types |
| TBX3 | Transcription factor in conduction system | Regulates Purkinje fiber development and gene expression |
| IRX3 | Transcription factor in ventricular conduction | Controls conduction system gene programs |
| NKX2-5 | Cardiac transcription factor | Regulates ion-channel and conduction gene expression |
How Is membrane depolarization during Purkinje myocyte cell action potential Regulated?
Regulation of membrane depolarization during Purkinje myocyte cell action potential involves voltage-dependent gating of ion channels, modulation by intracellular calcium, and electrotonic interactions with neighboring cells. Pharmacological agents such as calcium-channel blockers and antiarrhythmic drugs can modify the depolarizing currents and their balance. Coupling to depolarized cells can induce spontaneous activity, while electrotonic suppression can abolish early afterdepolarizations, indicating that the process is dynamically regulated by the surrounding electrical environment.
membrane depolarization during Purkinje myocyte cell action potential and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SCN5A | Cardiac arrhythmia and conduction defects | Knockout or point-mutation Purkinje myocyte model |
| CACNA1C | Calcium channel-related arrhythmia biology | Point-mutation knock-in in cardiac cell line |
| KCNH2 | Repolarization-related arrhythmia | Knockout and rescue overexpression model |
| GJA1 | Gap junction-mediated conduction disturbance | Knockout co-culture electrotonic coupling model |
| HCN4 | Conduction system pacemaker activity | Overexpression in Purkinje-like cells |
Cardiac arrhythmias
Abnormal depolarization and repolarization in Purkinje myocytes contribute to the pathophysiologic mechanisms of cardiac arrhythmias. Early afterdepolarizations in Purkinje cells can trigger arrhythmic activity, and their suppression by electrotonic interactions highlights the importance of the cellular environment.
Drug-induced proarrhythmia
Antiarrhythmic agents can have both therapeutic and arrhythmogenic effects on cardiac tissue, in part by altering depolarization and repolarization. Calcium-channel blockers modify inward currents that participate in depolarization, linking pharmacology to GO:0086047.
Conduction system dysfunction
Because Purkinje myocytes are specialized for rapid conduction, changes in their depolarization properties can affect impulse propagation and ventricular activation. Experimental isolation and characterization of conduction cells helps define how these changes arise.
From membrane depolarization during Purkinje myocyte cell action potential-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a sodium channel gene reduce depolarization rate? | Knockout Purkinje myocyte or cardiac cell line |
| Does a specific variant alter channel gating? | Point-mutation knock-in model |
| Can a reporter track conduction-cell identity? | Tagged knock-in of a Purkinje marker |
| Does overexpression of a calcium channel enhance inward current? | Overexpression model |
| How does gap junction loss affect electrotonic coupling? | Knockout co-culture model |
| Can a candidate gene rescue depolarization defects? | Rescue knock-in or overexpression model |
How to Study the membrane depolarization during Purkinje myocyte cell action potential Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Voltage clamp | Ionic currents during depolarization | Ion-channel mechanism studies |
| Microelectrode recording | Transmembrane action potential | Validation of action potential properties |
| Contact electrode mapping | Monophasic action potential | Comparison with intracellular recordings |
| Isolated Purkinje myocyte assay | Cell-level depolarization behavior | Coupling and afterdepolarization studies |
| Morphological imaging | Cell shape and identity | Conduction cell characterization |
| Pharmacological perfusion | Drug effects on depolarization | Antiarrhythmic and calcium blocker testing |
| CRISPR gene editing | Causal gene function | Knockout, knock-in, overexpression models |
Single-cell voltage clamp
Voltage clamp allows direct measurement of the ionic currents underlying depolarization in isolated cardiac cells and has been fundamental to understanding the cardiac action potential.
Microelectrode validation
Microelectrode recordings provide a reference for transmembrane action potential properties and have been used to validate contact-electrode measurements in isolated cardiac tissues.
Isolated Purkinje myocyte preparations
Enzymatic isolation of Purkinje myocytes enables controlled electrophysiological study of depolarization and its modulation by coupling or drugs.
Morphological and electrophysiological characterization
Combined morphological and electrophysiological analysis of single myocardial cells helps distinguish conduction cells from working myocardium and interpret depolarization behavior.
How CRISPR Can Be Used to Study GO:0086047 membrane depolarization during Purkinje myocyte cell action potential
Knockout
CRISPR knockout of ion-channel genes such as SCN5A or KCNH2 can test whether a specific current is required for normal depolarization in Purkinje myocyte models, guided by voltage-clamp readouts.
Point Mutation
Point-mutation knock-in allows precise testing of variants in calcium or sodium channel genes for their effects on depolarization, complementing pharmacological studies with calcium-channel blockers.
Knock-in
Tagged knock-in of conduction-system markers or channels enables visualization and functional tracking of Purkinje myocytes in culture and in vivo.
Overexpression
Overexpression of inward-current channels or gap junction proteins can enhance or restore depolarization and electrotonic coupling, providing gain-of-function tests for candidate genes.
How EDITGENE Supports membrane depolarization during Purkinje myocyte cell action potential Research
Researchers studying membrane depolarization during Purkinje myocyte cell action potential-related genes often need to determine whether a candidate gene is causally involved in setting the depolarizing current, the peak potential, or the coupling behavior of conduction cells. EDITGENE provides the CRISPR cell models and screening services needed to move from correlation to causation in this specialized electrophysiological context.
Contact EDITGENE today to design your custom CRISPR model for membrane depolarization during Purkinje myocyte cell action potential research.
Frequently Asked Questions About membrane depolarization during Purkinje myocyte cell action potential
What is GO:0086047?
GO:0086047 is the biological process of membrane depolarization during Purkinje myocyte cell action potential, in which the Purkinje myocyte membrane potential moves from the negative resting potential toward the positive action potential peak.
What happens during membrane depolarization in Purkinje myocytes?
Inward ion currents activate and drive the membrane potential in the depolarizing direction, balanced by outward currents, until the action potential peak is reached.
What genes are involved in Purkinje myocyte depolarization?
Genes encoding cardiac sodium, calcium, and potassium channels, gap junction proteins, and conduction-system transcription factors are involved.
Why are Purkinje myocytes important for heart rhythm?
Purkinje myocytes form the fast ventricular conduction system, and their depolarization ensures coordinated ventricular activation.
How is Purkinje myocyte depolarization studied?
Single-cell voltage clamp, microelectrode recording, and isolated Purkinje myocyte preparations are standard approaches.
Can calcium-channel blockers affect Purkinje depolarization?
Yes, calcium-channel blockers modify inward calcium currents that contribute to depolarization and conduction.
What are early afterdepolarizations in Purkinje myocytes?
They are abnormal depolarizing events that can trigger arrhythmias and can be suppressed by electrotonic interactions.
How does electrotonic coupling affect Purkinje myocytes?
Coupling to a depolarized cell can induce spontaneous activity, while electrotonic suppression can abolish afterdepolarizations.
What CRISPR models are useful for this process?
Knockout, point-mutation, knock-in, and overexpression models of ion-channel and gap-junction genes are useful for causal testing.
Is GO:0086047 the same as depolarization in working myocardium?
No, GO:0086047 specifically refers to depolarization in Purkinje myocytes of the conduction system, which have distinct electrophysiological properties.
Conclusion
GO:0086047 provides a precise ontology handle for the depolarizing phase of the Purkinje myocyte action potential, a process central to rapid ventricular conduction and cardiac rhythm. Its ionic basis, modulation by electrotonic coupling, and pharmacological sensitivity are well supported by voltage-clamp and isolated-cell studies. For researchers, combining classical electrophysiology with CRISPR-based knockout, point-mutation, knock-in, and overexpression models offers a rigorous path to causal gene discovery in this specialized conduction-cell process.
References
- 1. Wit AL et al.. 1983. Pathophysiologic mechanisms of cardiac arrhythmias.. Am Heart J 106(4 Pt 2):798-811 PMID: 6310978
- 2. Varró A et al.. 1992. The impact of single cell voltage clamp on the understanding of the cardiac ventricular action potential.. Cardioscience 3(3):131-44 PMID: 1384746
- 3. Katz AM. 1985. Basic cellular mechanisms of action of the calcium-channel blockers.. Am J Cardiol 55(3):2B-9B PMID: 2578725
- 4. Ino T et al.. 1988. Relation of monophasic action potential recorded with contact electrode to underlying transmembrane action potential properties in isolated cardiac tissues: a systematic microelectrode validation study.. Cardiovasc Res 22(4):255-64 PMID: 3197056
- 5. Dangman KH et al.. 1981. In vivo and in vitro antiarrhythmic and arrhythmogenic effects of N-acetyl procainamide.. J Pharmacol Exp Ther 217(3):851-62 PMID: 6164783
- 6. Huelsing DJ et al.. 2003. Spontaneous activity induced in rabbit Purkinje myocytes during coupling to a depolarized model cell.. Cardiovasc Res 59(3):620-7 PMID: 14499863
- 7. Huelsing DJ et al.. 2000. Electrotonic suppression of early afterdepolarizations in isolated rabbit Purkinje myocytes.. Am J Physiol Heart Circ Physiol 279(1):H250-9 PMID: 10899064
- 8. Ren FX et al.. 2006. Morphological and electrophysiological properties of single myocardial cells from Koch triangle of rabbit heart.. Chin Med J (Engl) 119(24):2075-84 PMID: 17199959
